Cargando…

Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases—The Case for Using Ignored Target Cell Antigen Determinants

We have proposed that antigen-specific immunotherapies (ASIs) for autoimmune diseases could be enhanced by administering target cell antigen epitopes (determinants) that are immunogenic but ignored by autoreactive T cells because these determinants may have large pools of naïve cognate T cells avail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Jide, Song, Min, Kaufman, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997884/ https://www.ncbi.nlm.nih.gov/pubmed/35406645 http://dx.doi.org/10.3390/cells11071081

Ejemplares similares

Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
por: Streeter, Heather B, et al.
Publicado: (2021)

Antigen-specific immunotherapy of autoimmune and allergic diseases
por: Sabatos-Peyton, Catherine A, et al.
Publicado: (2010)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
por: Richardson, Naomi, et al.
Publicado: (2020)

Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity
por: Richardson, Naomi, et al.
Publicado: (2021)

Correction to: Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity
Publicado: (2023)

Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored
por: Pan, Shu-Yue, et al.
Publicado: (2022)

Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2011)

Antigen-based immunotherapy for autoimmune disease: current status
por: Hirsch, Darren Lowell, et al.
Publicado: (2014)

The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases
por: Shepard, Ella R., et al.
Publicado: (2021)

Oral tolerance as antigen-specific immunotherapy
por: Pinheiro-Rosa, Natália, et al.
Publicado: (2021)

Phosphorylation of Human Polyomavirus Large and Small T Antigens: An Ignored Research Field
por: Moens, Ugo, et al.
Publicado: (2023)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens
por: Gubin, Matthew M., et al.
Publicado: (2014)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
por: Kelderman, Sander, et al.
Publicado: (2013)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders
por: Cleenewerk, L., et al.
Publicado: (2020)

Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022)

Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy
por: Song, Jianxun
Publicado: (2016)

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
por: Xu, Bo, et al.
Publicado: (2022)

Transgenically Induced GAD Tolerance Curtails the Development of Early β-Cell Autoreactivities but Causes the Subsequent Development of Supernormal Autoreactivities to Other β-Cell Antigens
por: Tian, Jide, et al.
Publicado: (2009)

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
por: Kiessling, Andrea, et al.
Publicado: (2012)

Antigen-specific immunotherapy for MOG antibody-associated diseases
por: Nessler, Stefan
Publicado: (2019)

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2021)

Inclusion of Strep-Tag II in design of antigen receptors for T cell immunotherapy
por: Liu, Lingfeng, et al.
Publicado: (2016)

T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
por: Woodham, Andrew W., et al.
Publicado: (2016)

Increased risk for T cell autoreactivity to ß-cell antigens in the mice expressing the A(vy) obesity-associated gene
por: Yong, Jing, et al.
Publicado: (2019)

Autoimmune Cholangitis in the SJL/J Mouse is Antigen Non-specific
por: Sasaki, Motoko, et al.
Publicado: (2002)

Dominant nonresponsiveness in the induction of autoimmunity to liver- specific F antigen
Publicado: (1975)

Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases
por: Benne, Naomi, et al.
Publicado: (2022)

Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation
por: Selck, Claudia, et al.
Publicado: (2021)

Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
por: Creusot, Rémi J., et al.
Publicado: (2018)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia
por: Kadowaki, Norimitsu, et al.
Publicado: (2011)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gh7lun6ilb0vdp2qvhqqg1fitp